Literature DB >> 34131820

ASO Author Reflections: Multimodality Treatment in Anaplastic Thyroid Cancer: Improving Survival Outcomes and Balancing Treatment Related Complications.

Pascal K C Jonker1,2, Mark Sywak3,4.   

Abstract

Entities:  

Year:  2021        PMID: 34131820     DOI: 10.1245/s10434-021-10268-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment.

Authors:  Pascal K C Jonker; John Turchini; Schelto Kruijff; Jia Feng Lin; Anthony J Gill; Thomas Eade; Ahmad Ahniss; Roderick Clifton-Bligh; Diana Learoyd; Bruce Robinson; Venessa Tsang; Anthony Glover; Stanley Sidhu; Mark Sywak
Journal:  Ann Surg Oncol       Date:  2021-05-25       Impact factor: 5.344

Review 2.  The value of research collaborations and consortia in rare cancers.

Authors:  Jean-Yves Blay; Jean-Michel Coindre; Françoise Ducimetière; Isabelle Ray-Coquard
Journal:  Lancet Oncol       Date:  2016-02       Impact factor: 41.316

Review 3.  Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Authors:  Eleonora Molinaro; Cristina Romei; Agnese Biagini; Elena Sabini; Laura Agate; Salvatore Mazzeo; Gabriele Materazzi; Stefano Sellari-Franceschini; Alessandro Ribechini; Liborio Torregrossa; Fulvio Basolo; Paolo Vitti; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2017-07-14       Impact factor: 43.330

4.  Identification of novel therapeutic targets in anaplastic thyroid carcinoma using functional genomic mRNA-profiling: Paving the way for new avenues?

Authors:  Pascal K C Jonker; Gooitzen M van Dam; Sjoukje F Oosting; Schelto Kruijff; Rudolf S N Fehrmann
Journal:  Surgery       Date:  2016-11-16       Impact factor: 3.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.